STOCK TITAN

PEN insider files Form 144 to sell 186 shares acquired as award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Penumbra, Inc. notice reports a proposed sale of 186 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $50,627.34. The shares represent stock awards acquired from Penumbra, Inc. on 03/31/2025. The filing states the approximate date of sale as 09/02/2025 and identifies the NYSE as the exchange. The filer reports 38,999,129 shares outstanding for the class, and indicates no other sales by the person in the past three months.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine Form 144 notice for a small award sale; immaterial versus total outstanding shares.

The filing documents a planned disposition of 186 shares received as a stock award, to be executed through Fidelity on the NYSE. The aggregate value reported is $50,627.34, against 38,999,129 shares outstanding, indicating the sale is immaterial to overall capitalization and is consistent with routine insider liquidity following a stock award. No other sales in the prior three months are reported, and the acquisition and reported payment date are the same (03/31/2025), with payment described as N/A, reflecting an awarded grant rather than a cash purchase.

TL;DR: Disclosure aligns with standard Rule 144 procedures; representation about material nonpublic information is included.

The filer confirms the representation required by the form that they are unaware of undisclosed material adverse information. The notice lists the broker, planned sale date, and the nature of acquisition as a stock award from the issuer, which satisfies transparency expectations for insider transactions. No indications of accelerated or unusual selling activity are present in this filing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Penumbra (PEN) Form 144 disclose?

The Form 144 discloses a proposed sale of 186 shares of common stock acquired as a stock award from Penumbra, with an aggregate market value of $50,627.34.

When is the approximate sale date listed on the PEN Form 144?

The approximate sale date is listed as 09/02/2025.

Through which broker will the PEN shares be sold?

The filing names Fidelity Brokerage Services LLC at 245 Summer Street, Boston, MA as the broker for the sale.

How many PEN shares outstanding does the filing report?

The filing reports 38,999,129 shares outstanding for the class referenced.

Were there any PEN shares sold by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

13.73B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA